Tag
Biogen Pharmachem Industries Limited
2 articles
Biogen Pharmachem No Unutilized Funds Disclosure
Biogen Pharmachem discloses no unutilized funds from past capital raises as of September 30, 2026.
Filing is a regulatory compliance submission under SEBI Listing Regulations and Circular CIR/CFD/CMD1
Biogen Pharmachem Q2 Net Profit ₹25.73 Lakh
Board approved unaudited Q2 FY27 results with net profit of ₹25.73 lakh, driven solely by other income as revenue remains nil.
Half-year net profit stands at ₹47.87 lakh, a decline from ₹85.33 lakh in